Tag: business news
-
3 ways the pros are trading, including why Goldman Sachs likes defense stocks
Skip NavigationMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting ClubPROLivestreamMenuThe S & P 500 is on track for its longest weekly win streak since 1985, as investors count down to May’s nonfarm
-
Tracking website, food watch: South Korea is obsessing over Nvidia CEO Jensen Huang’s visit
South Korean investors are eagerly tracking Nvidia CEO Jensen Huang’s every move as they wait to see what the AI megacap company will do next.
-
Cramer’s lightning round: Woodward is ‘a very good company’
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
-
Lululemon cuts annual outlook, citing ‘negative’ media commentary and disappointing product launches
Lululemon is expecting its situation to get a lot worse before it gets better, as it issued weak guidance for the full year.
-
Trump says Pulte won’t be permanent national intelligence director
Trump’s comment came two days after he tapped Bill Pulte, who leads the Federal Housing Finance Agency, as acting DNI to replace Tulsi Gabbard.
-
These income funds offer double-digit yields – but come with cost and complexity. How they work
Autocallable ETFs offer attractive coupon payments, but investors should prepare to do some homework if they’re exploring these funds.
-
The May jobs report will be released Friday. Here’s what to expect
The stronger-than-expected start this year for job creation could be in for a reality check.
-
Jim Cramer’s second half of the year playbook: Where stocks, oil, and rates are going
With the market nearing the halfway point of the year, investors have plenty of questions.
-
Sen. Bill Cassidy signs onto brief calling ‘anti-weaponization’ fund a ‘dire threat’
Sen. Bill Cassidy joined an amicus brief calling the Justice Department “anti-weaponization” fund a “dire threat.”
-
This drugmaker is developing breakthroughs like an ‘EpiPen for heart attacks.’ The market has yet to give it credit
The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an “EpiPen for heart attacks.”
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany india Investment strategy iran Iran war markets People per politics return russia S&P 500 Index said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
